Home Magazines Editors-in-Chief FAQs Contact Us

Clinical-pathological characteristics and management of fusocellular tumors. Our experience

Obstetrics & Gynecology International Journal
Abate Camila R, Urey Gian K, Costa M Florencia, Maltagliatti Daniela, Sanchotena Veronica, Santoro Laura, Flaks Diego, Arias Claudia


Introduction: Fucocellular tumors encompass a spectrum of very rare entities. Prognostic factors for the risk of relapse and overall survival such as tumor size, surgical margin, histological strain, and stromal growth are described.
Materials and methods: Observational, analytical and cross-sectional study, which studied patients with a diagnosis of fusocellular tumor, treated in the Breast Pathology Service of the Marie Curie Municipal Oncology Hospital (HOMC) of Buenos Aires during the period 2003 to 2022. Quantitative variables were used and analyzed with measures of central tendency. For the comparison of these variables, the Chi 2/Fisher exact test was used.
Results: A total of 58 patients with diagnosis of spindle-cell lesions were recruited, including Filode tumors, sarcomas, hamartomas, adenomyoepithelioma, aggressive fibromatosis, gigantocellular granuloma, fusocellular lesion.
Conclusion: It was observed that early age (<40 years) is not a risk factor for relapse, with an increase in this index in patients with tumor size > 5 cm. The percentage of relapses was not modified when conservative surgeries vs mastectomies were compared.


fusocellular tumors, phyllodes tumors, breast sarcomas